投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量45.74% (2022年為40.37%)
自引率
7.0 %
年文章數(shù)
5885
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):15849)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):6272次)
作者需知
暫無(wú)數(shù)據(jù)
NCBI查詢
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
The journal publishes papers on the science and technology of the controlled release and delivery of drugs and other agents. The terms "controlled release" and "delivery" are used in their broadest sense to include mechanisms such as diffusion, chemical and enzymatic reactions, dissolution, osmosis, targeting, and the utilization and manipulation of biological processes. A broad spectrum of papers dealing with all aspects of controlled release and delivery, including gene delivery, tissue engineering and diagnostic agents, is encouraged. The use of prodrugs and carriers such as water-soluble polymers, micro- and nanoparticles, liposomes and micelles is included in the scope. Relevant papers on the toxicology and biocompatibility of drug delivery systems are also published. In addition to original full length papers, notes, reviews and rapid communications, the journal includes book reviews, reports of future meetings, and announcements pertaining to the activities of the Controlled Release Society.
常用鏈接
期刊論壇
|
中國(guó)SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
